| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.895 | 0.003 | 0.895 | Vasodilator, peripheral | 0.802 0.004 DBMET00320 | ||
| 0.754 | 0.005 | 0.754 | Spasmolytic | 0.745 0.005 DBMET00320 | ||
| 0.709 | 0.013 | 0.772 | Analgesic | 0.772 0.008 DBMET00320 | DBMET00320 | |
| 0.435 | 0.018 | 0.435 | Vasodilator | 0.364 0.03 DBMET00320 | ||
| 0.384 | 0.004 | 0.433 | Opioid kappa receptor antagonist | 0.433 0.004 DBMET00320 | DBMET00320 | |
| 0.407 | 0.028 | 0.407 | Hypoxia-inducible factor 1 alpha inhibitor | 0.33 0.052 DBMET00320 | ||
| 0.392 | 0.041 | 0.425 | Nootropic | 0.425 0.032 DBMET00320 | DBMET00320 | |
| 0.339 | 0.005 | 0.339 | Acetylcholine nicotinic antagonist | 0.145 0.022 DBMET00320 | ||
| 0.337 | 0.004 | 0.337 | Neuronal nicotinic receptor antagonist | 0.123 0.017 DBMET00320 | ||
| 0.29 | 0.015 | 0.29 | Cholinergic antagonist | 0.213 0.029 DBMET00320 | ||
| 0.278 | 0.006 | 0.45 | Opioid antagonist | 0.45 0.004 DBMET00320 | DBMET00320 | |
| 0.28 | 0.016 | 0.28 | Acetylcholine antagonist | 0.206 0.029 DBMET00320 | ||
| 0.272 | 0.009 | 0.393 | Neurotrophic factor | 0.393 0.005 DBMET00320 | DBMET00320 | |
| 0.231 | 0.004 | 0.261 | Opioid kappa receptor agonist | 0.261 0.004 DBMET00320 | DBMET00320 | |
| 0.221 | 0.007 | 0.369 | Opioid mu receptor antagonist | 0.369 0.004 DBMET00320 | DBMET00320 | |
| 0.242 | 0.029 | 0.474 | Protein kinase stimulant | 0.474 0.005 DBMET00320 | DBMET00320 | |
| 0.281 | 0.079 | 0.296 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.296 0.067 DBMET00320 | DBMET00320 | |
| 0.263 | 0.061 | 0.315 | 5 Hydroxytryptamine 1E antagonist | 0.315 0.021 DBMET00320 | DBMET00320 | |
| 0.204 | 0.005 | 0.204 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.038 DBMET00320 | ||
| 0.194 | 0.012 | 0.273 | Opioid delta receptor antagonist | 0.273 0.005 DBMET00320 | DBMET00320 | |
| 0.183 | 0.005 | 0.342 | Opioid agonist | 0.342 0.004 DBMET00320 | DBMET00320 | |
| 0.178 | 0.005 | 0.275 | Opioid mu receptor agonist | 0.275 0.004 DBMET00320 | DBMET00320 | |
| 0.18 | 0.011 | 0.32 | Analgesic, opioid | 0.32 0.005 DBMET00320 | DBMET00320 | |
| 0.171 | 0.005 | 0.171 | Nicotinic alpha4beta2 receptor antagonist | 0.071 0.061 DBMET00320 | ||
| 0.163 | 0.005 | 0.163 | Nicotinic receptor alpha7 subunit antagonist | 0.082 0.016 DBMET00320 | ||
| 0.141 | 0.003 | 0.189 | Prolactin release inhibitor | 0.189 0.002 DBMET00320 | DBMET00320 | |
| 0.118 | 0.006 | 0.118 | Nicotinic receptor alpha4 subunit antagonist | 0.074 0.015 DBMET00320 | ||
| 0.121 | 0.012 | 0.128 | Protein kinase C eta inhibitor | 0.128 0.01 DBMET00320 | DBMET00320 | |
| 0.183 | 0.077 | 0.183 | P-glycoprotein inhibitor | 0.167 0.093 DBMET00320 | ||
| 0.118 | 0.016 | 0.118 | Protein kinase C alpha inhibitor | 0.102 0.022 DBMET00320 | ||
| 0.243 | 0.153 | 0.295 | Immunosuppressant | 0.295 0.118 DBMET00320 | DBMET00320 | |
| 0.095 | 0.008 | 0.095 | 5 Hydroxytryptamine 4 antagonist | 0.074 0.015 DBMET00320 | ||
| 0.112 | 0.027 | 0.433 | 5 Hydroxytryptamine 1F antagonist | 0.433 0.004 DBMET00320 | DBMET00320 | |
| 0.115 | 0.04 | 0.115 | Protein kinase C delta inhibitor | 0.111 0.043 DBMET00320 | ||
| 0.118 | 0.046 | 0.14 | Toll-Like receptor 4 antagonist | 0.14 0.027 DBMET00320 | DBMET00320 | |
| 0.262 | 0.193 | 0.385 | Calcium channel L-type activator | 0.385 0.091 DBMET00320 | DBMET00320 | |
| 0.097 | 0.029 | 0.277 | Dopamine agonist | 0.277 0.005 DBMET00320 | DBMET00320 | |
| 0.107 | 0.044 | 0.171 | Antineoplastic alkaloid | 0.171 0.022 DBMET00320 | DBMET00320 | |
| 0.065 | 0.021 | 0.065 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.046 DBMET00320 | ||
| 0.134 | 0.098 | 0.318 | Sigma receptor agonist | 0.318 0.036 DBMET00320 | DBMET00320 | |
| 0.069 | 0.035 | 0.095 | Adrenaline uptake inhibitor | 0.095 0.02 DBMET00320 | DBMET00320 | |
| 0.048 | 0.014 | 0.091 | Opioid delta receptor agonist | 0.091 0.005 DBMET00320 | DBMET00320 | |
| 0.056 | 0.023 | 0.056 | Farnesyltransferase inhibitor | |||
| 0.09 | 0.063 | 0.206 | Antiadrenergic | 0.206 0.023 DBMET00320 | DBMET00320 | |
| 0.039 | 0.013 | 0.039 | Protein kinase C beta II inhibitor | 0.037 0.014 DBMET00320 | ||
| 0.037 | 0.014 | 0.038 | Protein kinase C beta I inhibitor | 0.038 0.011 DBMET00320 | DBMET00320 | |
| 0.09 | 0.067 | 0.345 | Prolactin inhibitor | 0.345 0.003 DBMET00320 | DBMET00320 | |
| 0.084 | 0.065 | 0.197 | Adrenaline antagonist | 0.197 0.024 DBMET00320 | DBMET00320 | |
| 0.1 | 0.083 | 0.242 | 5 Hydroxytryptamine 2B antagonist | 0.242 0.02 DBMET00320 | DBMET00320 | |
| 0.117 | 0.112 | 0.161 | Acetylcholine M1 receptor antagonist | 0.161 0.065 DBMET00320 | DBMET00320 | |
| 0.06 | 0.056 | 0.06 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.026 | 0.026 | 0.076 | 5 Hydroxytryptamine 6 agonist | 0.076 0.003 DBMET00320 | DBMET00320 | |
| 0.057 | 0.058 | 0.264 | 5 Hydroxytryptamine agonist | 0.264 0.01 DBMET00320 | DBMET00320 | |
| 0.034 | 0.038 | 0.076 | Dopamine D5 antagonist | 0.076 0.013 DBMET00320 | DBMET00320 | |
| 0.038 | 0.043 | 0.055 | Sigma receptor antagonist | 0.055 0.031 DBMET00320 | DBMET00320 | |
| 0.033 | 0.041 | 0.14 | Dopamine D2 agonist | 0.14 0.007 DBMET00320 | DBMET00320 | |
| 0.071 | 0.08 | 0.327 | Alpha adrenoreceptor antagonist | 0.327 0.014 DBMET00320 | DBMET00320 | |
| 0.114 | 0.128 | 0.183 | MAP3K9 inhibitor | 0.183 0.024 DBMET00320 | DBMET00320 | |
| 0.033 | 0.06 | 0.045 | Dopamine transporter inhibitor | 0.045 0.037 DBMET00320 | DBMET00320 | |
| 0.051 | 0.078 | 0.228 | Alpha 1 adrenoreceptor antagonist | 0.228 0.017 DBMET00320 | DBMET00320 | |
| 0.079 | 0.108 | 0.107 | Alpha 2d adrenoreceptor antagonist | 0.107 0.037 DBMET00320 | DBMET00320 | |
| 0.069 | 0.1 | 0.093 | Protein kinase C mu inhibitor | 0.093 0.064 DBMET00320 | DBMET00320 | |
| 0.08 | 0.117 | 0.124 | Protein kinase C gamma inhibitor | 0.124 0.049 DBMET00320 | DBMET00320 | |
| 0.067 | 0.111 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.047 DBMET00320 | DBMET00320 | |
| 0.066 | 0.119 | 0.149 | 5 Hydroxytryptamine antagonist | 0.149 0.05 DBMET00320 | DBMET00320 | |
| 0.031 | 0.089 | 0.069 | Dopamine uptake inhibitor | 0.069 0.031 DBMET00320 | DBMET00320 | |
| 0.073 | 0.133 | 0.114 | Acetylcholine muscarinic antagonist | 0.114 0.073 DBMET00320 | DBMET00320 | |
| 0.032 | 0.092 | 0.076 | 5 Hydroxytryptamine 7 antagonist | 0.076 0.033 DBMET00320 | DBMET00320 | |
| 0.043 | 0.106 | 0.104 | Protein kinase C beta inhibitor | 0.104 0.012 DBMET00320 | DBMET00320 | |
| 0.011 | 0.076 | 0.022 | Dopamine D1 agonist | 0.022 0.016 DBMET00320 | DBMET00320 | |
| 0.049 | 0.117 | 0.127 | 5 Hydroxytryptamine 2C antagonist | 0.127 0.033 DBMET00320 | DBMET00320 | |
| 0.027 | 0.099 | 0.075 | 5 Hydroxytryptamine uptake inhibitor | 0.075 0.036 DBMET00320 | DBMET00320 | |
| 0.016 | 0.101 | 0.044 | Somatostatin 1 antagonist | 0.044 0.023 DBMET00320 | DBMET00320 | |
| 0.019 | 0.105 | 0.035 | Substance P antagonist | 0.035 0.034 DBMET00320 | DBMET00320 | |
| 0.123 | 0.211 | 0.234 | Cyclic AMP phosphodiesterase inhibitor | 0.234 0.072 DBMET00320 | DBMET00320 | |
| 0.054 | 0.147 | 0.172 | 5 Hydroxytryptamine 2 antagonist | 0.172 0.037 DBMET00320 | DBMET00320 | |
| 0.043 | 0.145 | 0.246 | Alpha 2 adrenoreceptor antagonist | 0.246 0.012 DBMET00320 | DBMET00320 | |
| 0.051 | 0.181 | 0.148 | Alpha 2c adrenoreceptor antagonist | 0.148 0.033 DBMET00320 | DBMET00320 | |
| 0.01 | 0.141 | 0.046 | 5 Hydroxytryptamine 1A agonist | 0.046 0.032 DBMET00320 | DBMET00320 | |
| 0.012 | 0.148 | 0.12 | 5 Hydroxytryptamine 1 agonist | 0.12 0.017 DBMET00320 | DBMET00320 | |
| 0.05 | 0.188 | 0.147 | Alpha 2b adrenoreceptor antagonist | 0.147 0.04 DBMET00320 | DBMET00320 | |
| 0.021 | 0.172 | 0.206 | 5 Hydroxytryptamine 1B antagonist | 0.206 0.008 DBMET00320 | DBMET00320 | |
| 0.024 | 0.197 | 0.094 | Dopamine D1 antagonist | 0.094 0.027 DBMET00320 | DBMET00320 | |
| 0.017 | 0.194 | 0.115 | 5 Hydroxytryptamine 1D antagonist | 0.115 0.018 DBMET00320 | DBMET00320 | |
| 0.024 | 0.203 | 0.071 | 5 Hydroxytryptamine 1B agonist | 0.071 0.017 DBMET00320 | DBMET00320 | |
| 0.021 | 0.205 | 0.122 | 5 Hydroxytryptamine 2A antagonist | 0.122 0.037 DBMET00320 | DBMET00320 | |
| 0.016 | 0.214 | 0.076 | Dopamine antagonist | 0.076 0.05 DBMET00320 | DBMET00320 | |
| 0.012 | 0.211 | 0.069 | Alpha 1a adrenoreceptor antagonist | 0.069 0.052 DBMET00320 | DBMET00320 | |
| 0.01 | 0.21 | 0.062 | 5 Hydroxytryptamine 2 agonist | 0.062 0.025 DBMET00320 | DBMET00320 | |
| 0.043 | 0.244 | 0.097 | Alkylator | 0.097 0.092 DBMET00320 | DBMET00320 | |
| 0.029 | 0.234 | 0.068 | 5 Hydroxytryptamine 5A antagonist | 0.068 0.033 DBMET00320 | DBMET00320 | |
| 0.151 | 0.365 | 0.197 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.197 0.175 DBMET00320 | DBMET00320 | |
| 0.004 | 0.219 | 0.045 | 5 Hydroxytryptamine 1D agonist | 0.045 0.012 DBMET00320 | DBMET00320 | |
| 0.025 | 0.247 | 0.06 | 5 Hydroxytryptamine 5 antagonist | 0.06 0.037 DBMET00320 | DBMET00320 | |
| 0.01 | 0.237 | 0.059 | Dopamine D2 antagonist | 0.059 0.05 DBMET00320 | DBMET00320 | |
| 0.084 | 0.311 | 0.141 | Lipocortins synthesis antagonist | 0.141 0.119 DBMET00320 | DBMET00320 | |
| 0.036 | 0.272 | 0.083 | Protein kinase C zeta inhibitor | 0.083 0.08 DBMET00320 | DBMET00320 | |
| 0.008 | 0.252 | 0.052 | Alpha 1d adrenoreceptor antagonist | 0.052 0.047 DBMET00320 | DBMET00320 | |
| 0.022 | 0.271 | 0.083 | Alpha 2a adrenoreceptor antagonist | 0.083 0.046 DBMET00320 | DBMET00320 | |
| 0.095 | 0.348 | 0.802 | 5 Hydroxytryptamine release stimulant | 0.802 0.004 DBMET00320 | DBMET00320 | |
| 0.011 | 0.295 | 0.14 | 5 Hydroxytryptamine 1 antagonist | 0.14 0.025 DBMET00320 | DBMET00320 | |
| 0.018 | 0.311 | 0.063 | 5 Hydroxytryptamine 7 agonist | 0.063 0.027 DBMET00320 | DBMET00320 | |
| 0.012 | 0.333 | 0.094 | 5 Hydroxytryptamine 2A agonist | 0.094 0.017 DBMET00320 | DBMET00320 | |
| 0.022 | 0.414 | 0.253 | Psychostimulant | 0.253 0.057 DBMET00320 | DBMET00320 | |
| 0.004 | 0.414 | 0.073 | 5 Hydroxytryptamine 1A antagonist | 0.073 0.044 DBMET00320 | DBMET00320 | |
| 0.072 | 0.589 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.133 0.101 DBMET00320 | DBMET00320 | |
| 0.052 | 0.721 | 0.203 | Tyrosine 3 hydroxylase inhibitor | 0.203 0.13 DBMET00320 | DBMET00320 | |
| 0.062 | 0.76 | 0.203 | 5 Hydroxytryptamine uptake stimulant | 0.203 0.146 DBMET00320 | DBMET00320 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |